70 McIlleron H, Meintjes G, Burman WJ, et al. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 2007 196: Suppl. 1, S63–S75. 71 WHO. Consolidated Guidelines on HIV, Viral Hepatitis and STI Prevention, Diagnosis, Treatment and Care for Key Populations. Geneva, WHO, 2022. 72 Allwood BW, Byrne A, Meghji J, et al. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Respiration 2021 100: 751–763. 73 Allwood BW, van der Zalm MM, Amaral AFS, et al. Post-tuberculosis lung health: perspectives from the First International Symposium. Int J Tuberc Lung Dis 2020 24: 820–828. 74 Nkereuwem E, Agbla S, Sallahdeen A, et al. Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study. Thorax 2023 78: 281–287. 75 Maleche-Obimbo E, Odhiambo MA, Njeri L, et al. Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: a systematic review and meta-analysis. PLoS Glob Public Health 2022 2: e0000805. 76 Chiang SS. Clinical standards for drug-susceptible TB in children and adolescents. Int J Tuberc Lung Dis 2022 26: 592–604. 77 Treatment Action Group/Child and Adolescent TB Working Group. Research Priorities for Paediatric Tuberculosis. TAG and WHO. New York, Treatment Action Group, 2018. www.treatmentactiongroup.org/ wp-content/uploads/2018/09/Paediatric_TB_ResearchPriorities_10_8_18_Web.pdf Support statement: ISGlobal receives support from: the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa 2019–2023 Program (CEX2018–000806-S) and the Generalitat de Catalunya through the CERCA Program. E. López-Varela has received funding from the European Respiratory Society and the European Union’s H2020 research and innovation programme under Marie Sklodowska-Curie grant agreement no. 847462. I. Munyangaju has received a fellowship from “La Caixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/DI21/11860045. Disclosures: None declared. 234 https://doi.org/10.1183/2312508X.10025322 ERS MONOGRAPH |THE CHALLENGE OF TB IN THE 21ST CENTURY